About: James H. Feusner

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: James H. Feusner Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

physician

Attributes	Values
rdf:type	Item
description	лікар (uk) physician (en)
rdfs:label	James H. Feusner (en) James H. Feusner (es) James H. Feusner (nl) James H. Feusner (sq)
skos:prefLabel	James H. Feusner (en) James H. Feusner (es) James H. Feusner (nl) James H. Feusner (sq)
name	James H. Feusner (en) James H. Feusner (es) James H. Feusner (nl) James H. Feusner (sq)
ResearchGate contributions ID	wds:Q99736016-b10d2c87-479e-5038-b338-957f66399088 wds:Q99736016-f969e769-4eb0-be16-1a59-3a4955ce8c71
ResearchGate contributions ID	39044154 63571828
Scopus author ID	wds:Q99736016-28d567b0-43dd-6f7e-71eb-fece70f41bd7 wds:Q99736016-9f88c57e-47fb-4d6b-4ec2-c4f9e7db8522
Scopus author ID	57210648441 7005710189
given name	wds:Q99736016-7ca680e5-481a-bd7c-91e4-97b9f0d8784e
given name	James
instance of	wds:Q99736016-e138fdde-46c5-6539-b25f-0ce8d68b6f43
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q99736016-732cfa79-45d1-dcd5-cb25-e52b9d5689ce
Google Knowledge Graph ID	http://g.co/kg/g/11hxmx8h7l
Google Knowledge Graph ID	/g/11hxmx8h7l
skos:altLabel	James Feusner (en) James H Feusner (en)
occupation	wds:Q99736016-ea8d55c1-41d2-0dc6-9b26-f7cb6baf4c4d
employer	wds:Q99736016-d26b4b26-43cb-e2ee-0f8b-dff55e7cc3e6
sex or gender	wds:Q99736016-4a089c35-415e-a6e9-20ed-72f88178ec89
educated at	wds:Q99736016-0254e1d6-4997-1bbf-0adc-e824951f5887 wds:Q99736016-f5d65498-4fd9-ff74-e4a4-3932e3b63c84
family name	wds:Q99736016-58faf9be-40ec-06c9-175e-0714dfd86078
occupation	physician
employer	University of Nevada, Reno School of Medicine
sex or gender	male
educated at	University of Washington
family name	Feusner
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q99736016
is author of	Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology Group Childhood cancer following neonatal oxygen supplementation All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. Acute promyelocytic leukemia in childhood Acute promyelocytic leukaemia in children FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129 Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Health-related quality of life in young survivors of childhood cancer using the Minneapolis-Manchester Quality of Life-Youth Form Platelet Counts in Capillary Blood Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group Mechanisms of thrombocytopenia in varicella FLT3 mutation incidence and timing of origin in a population case series of pediatric leukemia Hepatoblastoma clinical research: lessons learned and future challenges Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors Hepatoblastoma and low birth weight. Treatments and outcomes for end-stage renal disease following Wilms tumor. Hepatoblastoma and low birth weight: a trend or chance observation? Global characteristics of childhood acute promyelocytic leukemia Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia Mortality in overweight and underweight children with acute myeloid leukemia Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies? Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis Fibrolamellar hepatocellular carcinoma in children and adolescents Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16). Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941. Acquired haemostatic defects in the ill newborn Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California. Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemia Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective. All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129. Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor Management of tumor lysis syndrome: need for evidence-based guidelines The Minneapolis-Manchester Quality of Life instrument: Reliability and validity of the Youth Form. Assessment of health-related quality of life of adolescent cancer patients using the Minneapolis-Manchester Quality of Life Adolescent Questionnaire Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia. Birth characteristics and hepatoblastoma risk in young children Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy Hepatoblastoma in children with Beckwith-Wiedemann syndrome: does it warrant different treatment? Platelet transfusion "trigger" for lumbar puncture Impact of registration on clinical trials on infection risk in pediatric acute myeloid leukemia Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia Normal and abnormal bleeding times in neonates and young children utilizing a fully standardized template technic Association of hemorrhagic disease and the syndrome of persistent fetal circulation with the fetal hydantoin syndrome Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening Malignant abdominal masses in children: quick guide to evaluation and diagnosis Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631 Single nucleotide polymorphism in IL1B is associated with infection risk in paediatric acute myeloid leukaemia Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology Group

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software